IBM’s, Summer

IBM’s Summer of Contradictions: A Historic Rout, a Quantum Milestone, and a Patent Windfall

Published on 07/31/2026 at 06:02 | Redaktion boerse-global.de

IBM's stock fell 25% on weak earnings, yet quantum advances, a patent deal with Circle, and a century-old dividend streak signal long-term resilience.

IBM Stock Plunge vs Quantum Breakthroughs: A Tale of Two Narratives
IBM’s Summer of Contradictions: A Historic Rout, a Quantum Milestone, and a Patent Windfall Illustration mit AI erstellt übermittelt durch boerse-global.de

The numbers tell two stories that refuse to reconcile. IBM’s share price has been cut by more than a quarter since January, yet the company keeps handing investors reasons to look past the carnage. In the span of three weeks this summer, Big Blue unveiled a breakthrough in quantum computing, struck a patent deal with a major stablecoin player, and confirmed a dividend streak that stretches back more than a century. None of it has been enough to calm a market that watched the stock suffer its worst single-day loss on record.

The Day Everything Changed

July 14 marked an inflection point. Preliminary quarterly results came in below analyst expectations, and the market responded with a 25 percent single-day collapse — a move some observers described as the worst trading session in the company’s history. The damage was concentrated in the infrastructure division, where the flagship IBM Z mainframe business is losing ground as customers redirect capital toward AI chips and AI servers. CEO Arvind Krishna acknowledged the shift openly, and the company was forced to trim its full-year revenue guidance.

The software segment, buoyed by Red Hat, continues to grow. But that growth is being overshadowed by the structural decline in legacy hardware. IBM now expects currency-adjusted revenue growth of four to five percent for the year, with free cash flow projected to rise by roughly one billion US dollars.

A Quantum Counterweight

Nine days after the rout, on July 23, IBM announced the acquisition of HRL Laboratories, a pioneer in quantum-dot technology previously owned by Boeing and General Motors. The deal is expected to close by the end of the third quarter of 2026.

Should investors sell immediately? Or is it worth buying IBM?

A week later, on July 30, IBM and Algorithmiq reported progress toward “quantum advantage.” Using the Heron quantum processor, the teams simulated heterogeneous quantum materials — a task that has eluded classical supercomputers. Management has been candid that quantum computing will not contribute meaningfully to profits until the end of the decade. Until then, it remains a long-term bet requiring substantial capital with no near-term payoff.

The Patent Play

In a quieter but strategically significant move, IBM sold more than 680 patent families — nearly 1,000 granted patents worldwide — to Circle, the company behind the USDC stablecoin. The portfolio covers blockchain technology, banking, insurance, and cloud security. Financial terms were not disclosed.

Circle plans to deploy the intellectual property across its Arc blockchain, AI-driven financial tools, and the Circle Payments Network. Sarah Wilson, Circle’s General Counsel and Corporate Secretary, called the acquisition essential to the company’s mission of building infrastructure for internet-based global finance. The two firms said they would explore additional areas of collaboration.

IBM had already ranked among the largest holders of blockchain patents in the US, with a December 2025 analysis by PatSnap counting 790 patents — putting the company alongside Advanced New Technologies and Bank of America at the top of the list. That portfolio was built up since IBM’s blockchain push in the mid-2010s. The sale demonstrates how established technology firms can monetize dormant intellectual property, particularly at a moment when blockchain and stablecoin infrastructure is drawing renewed capital.

The Numbers Behind the Noise

The stock closed Thursday at 192.24 euros, down 2.89 percent on the day. That leaves the shares 34.36 percent below their 52-week high of 292.85 euros, reached in early June. Since the July low of 175.14 euros, the stock has recovered roughly ten percent, but the rebound looks fragile.

Technical indicators offer little comfort. The RSI sits at 39.4 — approaching but not yet entering oversold territory. Annualized 30-day volatility stands at nearly 86 percent, a figure that underscores just how jittery the market has become about the company’s transformation. Analyst price targets average 212.87 euros, implying upside of about ten percent from current levels, though that optimism feels tentative given the scale of the recent selloff.

IBM at a turning point? This analysis reveals what investors need to know now.

A Dividend as a Lifeline

Amid the turbulence, the board confirmed the regular quarterly dividend of 1.69 US dollars per share. The payment date is September 10, 2026, with the record date set for August 10. IBM has now paid a dividend every year since 1916 — one of the longest streaks in the US equity market. For shareholders, that payout is currently serving as a buffer against the falling share price, even as the company’s debt load during this transition remains a topic of debate.

The Core Question

The central tension of IBM’s summer is whether the quantum promise can gain substance quickly enough to offset double-digit declines in the traditional hardware business. The patent sale to Circle provides a small but visible demonstration that value can be unlocked beyond the core software and infrastructure operations. Whether that is enough to restore investor confidence depends on whether management delivers on its promised momentum in new business wins during the second half of the year.

Until the mainframe business stabilizes or quantum computing produces its first revenues, the stock appears destined to remain caught between two narratives — one of a legacy business in retreat, the other of a future that has not yet arrived.

Ad

IBM Stock: New Analysis - 31 July

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US4592001014 | IBM’S | boerse | 69903229 |